| Literature DB >> 26319999 |
Pascal P Klinger-Gratz1,2, Gerhard Schroth3, Jan Gralla1, Simon Jung1,4, Christian Weisstanner1, Rajeev K Verma1, Pasquale Mordasini1, Frauke Kellner-Weldon1, Kety Hsieh1, Mirjam R Heldner4, Urs Fischer4, Marcel Arnold4, Heinrich P Mattle4, Marwan El-Koussy1.
Abstract
INTRODUCTION: Diagnostic tools to show emboli reliably and protection techniques against embolization when employing stent retrievers are necessary to improve endovascular stroke therapy. The aim of the present study was to investigate iatrogenic emboli using susceptibility-weighted imaging (SWI) in an open series of patients who had been treated with stent retriever thrombectomy using emboli protection techniques.Entities:
Keywords: Collaterals; SWI; Stent retriever; Stroke; TICI
Mesh:
Year: 2015 PMID: 26319999 PMCID: PMC4602059 DOI: 10.1007/s00234-015-1583-8
Source DB: PubMed Journal: Neuroradiology ISSN: 0028-3940 Impact factor: 2.804
Fig. 1A 72-year-old man with mild aphasia and right-sided hemiparesis (NIHSS score 5). MRI shows left proximal MCA occlusion. On initial SWI, prominent veins in the region of the left Sylvian fissure are seen (a [axial, mIP] and b [coronal]). DWI shows diffusion restriction in the basal ganglia (c). Post-interventional SWI demonstrates a punctate signal drop corresponding to a peri-interventional embolus (d [white arrow, mIP] and e [black arrow]). The embolus is located outside of the infarcted area as seen on post-interventional DWI (f)
Fig. 2A 83-year-old man with right-sided hemiparesis (NIHSS score 21). Two separate thrombi in the left proximal M1 segment and the MCA bifurcation are seen on DSA (a, black arrows). Pre-interventional SWI shows thrombotic material in the proximal M1 segment and MCA bifurcation extending in an M2 branch (measuring 10 and 9 mm on SWI; d, white arrowhead) but no additional distal fragments (e). Two thrombus fragments were retrieved (c). Final biplane DSA control was rated as TICI 3 reperfusion (b). Post-interventional SWI detected one EE (f, white arrow) with an associated ischemic lesion on DWI (g). The sagittal reformatted projection of the SWI confirms the extracerebral location of the EE and its orientation along a suprasylvian MCA branch (h). Lateral DSA shows stagnating flow in the corresponding MCA branch with discretely diminished parenchymal blush during this phase of the DSA (i). (Artifacts are produced by simultaneous recording of NIRS)
Fig. 3The post-interventional SWI of this 76-year-old man with a stroke of NIHSS 13 shows the EE in a parietal branch of the right MCA (a). As demonstrated by the frozen lateral DSA projection, proximal stagnating of contrast flow in the sylvian segment about 2 cm in front of the EE (white ring) is compensated by retrograde flow in the suprasylvian branches, which have been identified in the initial DSA as collaterals, coming down from the anterior cerebral artery (b, black arrows). The resulting minimal blush as well as the visualization of all arteries in the AP projection may have been the reason that the interventional team rated the final DSA series as TICI 3 in this patient. The stagnating flow in the distal temporo-occipital branches is not related to EE but to still active collaterals from the vertebrobasilar system
Details of patients with emboli on post-interventional susceptibility-weighted imaging
| Case | Age/sex | Occlusion site | Baseline NIHSS score | Stroke etiology | Reperfusion grade (TICI) | Number of emboli | Location of emboli (outside/inside infarct) | Emboli associated with new ischemia | mRS score at 3 months |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 67/M | ICA/M2 | 11 | Large artery disease | 3 | 1 | Outside | No | 3 |
| 2 | 62/M | M1 | 7 | Cardioembolic | 3 | 2 | Outside | No | 1 |
| 3 | 72/M | M1 | 5 | Cardioembolic | 3 | 1 | Outside | No | 0 |
| 4 | 48/F | M1 | 9 | Unknown | 3 | 1 | Inside | No | 0 |
| 5 | 70/F | M1 | 5 | Cardioembolic | 3 | 1 | Outside | No | 1 |
| 6 | 75/F | M1 | 21 | Cardioembolic | 3 | 1 | Outside | Yes | 4 |
| 7 | 38/F | M2 | 5 | Other | 3 | 1 | Outside | No | 1 |
| 8 | 73/F | M1 | 14 | Unknown | 3 | 1 | Outside | No | Lost to follow-up |
| 9 | 68/F | M1 | 23 | Unknown | 2b | 1 | Outside | No | 0 |
| 10 | 77/M | M1 | 17 | Large artery disease | 2b | 3 | Inside | No | 3 |
| 11 | 76/M | M2 | 13 | Unknown | 3 | 1 | Inside | Yes | 1 |
| 12 | 83/M | M1 | 21 | Unknown | 3 | 1 | Outside | Yes | 3 |
| 13 | 79/F | Distal ICA | 14 | Cardioembolic | 2b | 1 | Inside | No | 6 |
NIHSS NIH Stroke Scale, TICI Thrombolysis in Cerebral Infarction, mRS modified Rankin Scale, M1 M1 segment of the MCA, M2 M2 segment of the MCA
Fig. 4The DSA of the dominant vertebral artery in this 79-year-old woman with occlusion of the internal carotid artery shows the retrograde filling of the posterior parietal branches of the MCA (a). Due to the still active collaterals from the vertebrobasilar system, not visible in the selective DSA, the interventional team rated this as TICI 2b based on the stagnating flow and diminished temporooccipital blush (b). Quality control MR the next day found neither EE nor DWI lesions in this area
Anterior circulation stroke: clinical, procedural, and outcome parameters in patients with and without peri-interventional embolic events
| Patients with emboli ( | Patients without emboli ( | |
|---|---|---|
| Intravenous thrombolysis, | 6 (46.2) | 21 (47.7) |
| Successful reperfusion (TICI 2b–3), | 13 (100) | 36 (81.8) |
| Interventional characteristics, | ||
| Distal access catheter use | 1 (7.7) | 14 (31.8) |
| Multimodal therapy | 5 (38.5) | 23 (52.3) |
| Thromboaspiration | 3 (23.1) | 15 (34.1) |
| Extracranial and intracranial stenting | 1 (7.7) | 9 (20.5) |
| Intraarterial thrombolysis | 1 (7.7) | 9 (20.5) |
| Anesthesia, | ||
| General anesthesia | 5 (38.5) | 32 (72.7) |
| Conscious sedation | 8 (61.5) | 12 (27.3) |
| Symptomatic ICH, | 0 (0.0) | 3 (6.8) |
| Asymptomatic ICH, | 3 (23.1) | 8 (18.2) |
| Favorable outcome (mRS score 0–2) at 3 months, | 7/12 (58.3) | 29/41 (70.7) |
| Dead at 3 months, | 1/12 (8.3) | 3/43 (7.0) |
| Stroke etiology, | ||
| Large artery disease | 2 (15.4) | 8 (18.2) |
| Cardioembolic | 5 (38.5) | 20 (45.5) |
| Other determined etiology | 1 (7.7) | 4 (9.1) |
| Unknown aetiology | 5 (38.5) | 12 (27.3) |
| Atrial fibrillation, | 5/12 (41.7) | 16/39 (41.0) |
| Thrombus length on pre-interventional SWI (mm), mean (SD) | 13.4 (10.1) ( | 12.8 (6.1) ( |
TICI Thrombolysis in Cerebral Infarction, mRS modified Rankin Scale, ICH intracranial hemorrhage
Trials on endovascular treatment of anterior circulation stroke: clinical outcome in relation to baseline NIHSS score and endovascular techniques applied
| Study designation | Number of patients undergoing endovascular treatment | Baseline NIHSS score, median | Favorable outcome (mRS score 0–2) at 3 months (%) | Endovascular techniques applied |
|---|---|---|---|---|
| PROACT II [ | 121 | 17 | 40 | ia prourokinase |
| MELT [ | 57 | 14 | 49 | ia urokinase |
| Mattle et al. [ | 55 | 17a | 53 | ia urokinase |
| Galimanis et al. [ | 623 | 15 | 49 | ia urokinase, aspiration, stent retriever (Solitaire) |
| Multi MERCI trial [ | 164 | 19 | 36 | Distal Thrombectomy (Merci) |
| Penumbra trial [ | 125 | 18a | 25 | Fragmentation/aspiration (Penumbra) |
| SWIFT [ | ||||
| - Merci | 58 | 18 | 28 | Merci |
| - Solitaire | 55 | 17 | 37 | Solitaire (protection not mandatory) |
| TREVO 2 [ | ||||
| - Merci | 90 | 18 | 22 | Merci |
| - TREVO | 88 | 19 | 40 | Stent retriever (Trevo, protection not mandatory) |
| MR CLEAN [ | 233 | 17 | 33 | ia alteplase or urokinase, thrombus retraction, aspiration, wire disruption, stent retriever (protection not mandatory) |
| IMS III [ | 434 | 17 | 41 | Merci, Penumbra, Solitaire (protection not mandatory), ia tPA |
| MR RESCUE [ | 64 | 16 (penumbral), 19 (non-penumbral | 19 | Merci, Penumbra, ia tPA |
| SYNTHESIS [ | 181 | 13 | 42 | ia tPA, wire disruption, Merci, Penumbra, Trevo, Solitaire (protection not mandatory) |
| Dávalos et al. [ | 141 | 18 | 55 | Solitaire (protection in 74 % of interventions) |
| STAR trial [ | 202 | 17 | 58 | Solitaire (protection mandatory) |
| ESCAPE trial [ | 165 | 16 | 53 | Stent retriever recommended (protection recommended) |
| EXTEND-IA trial [ | 35 | 17 | 71 | Solitaire (protection mandatory) |
| REVASCAT [ | 103 | 17 | 44 | Solitaire (protection not mandatory) |
| SWIFT prime [ | 98 | 17 | 60 | Solitaire (protection mandatory) |
ia intraarterial, NIHSS NIH Stroke Scale, mRS modified Rankin Scale
aMean